Moderna
MRNA
#1328
Rank
A$21.34 B
Marketcap
$55.48
Share price
5.34%
Change (1 day)
-63.41%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$21.34 Billion

As of February 2025 Moderna has a market cap of A$21.34 Billion. This makes Moderna the world's 1328th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025A$21.34 B-14.01%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Feb 22nd, 2025 the market cap of Moderna was reported to be:

A$21.34 Billion
by Nasdaq info icon info icon
A$21.34 Billion
by CompaniesMarketCap info icon info icon
A$21.40 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.13 B-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
A$353.52 B 1,555.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.3 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$50.65 B 137.27%๐Ÿ‡บ๐Ÿ‡ธ USA
A$337.24 B 1,479.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$3.91 B-81.65%๐Ÿ‡บ๐Ÿ‡ธ USA
A$610.16 B 2,757.96%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.64 B-78.22%๐Ÿ‡บ๐Ÿ‡ธ USA